angiotensin IV comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-08-19. Numbers and descriptions here follow the published literature rather than marketing material.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
| Property | Value | Notes |
|---|---|---|
| Chemical name | N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Common full name in research literature. |
| Class | Synthetic peptide | Modified angiotensin IV analog. |
| Related compound | Angiotensin IV | Parent peptide fragment. |
| Proposed target | HGF/c-Met pathway | Described as an HGF mimetic; not fully confirmed. |
| Development status | Preclinical research | No widely approved clinical use. |
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism of dihexa centers on activation of the hepatocyte growth factor receptor, also called c-Met. Some studies suggest it acts as a mimetic of hepatocyte growth factor, promoting signaling pathways involved in synapse formation. Other work has explored interactions with angiotensin IV pathways, but the exact binding targets remain uncertain. Laboratory findings come mainly from cell cultures and animal models. Whether these mechanisms operate similarly in humans is an open question. Researchers have not established a single, universally accepted mechanism of action.
Identity and purity of dihexa samples are typically assessed with high-performance liquid chromatography and mass spectrometry. These methods can confirm molecular mass and estimate the presence of impurities. However, a certificate of analysis from a supplier is not a guarantee of independent testing. Researchers often require in-house verification before using a peptide in experiments. For solid samples, appearance, solubility, and chromatographic profile provide additional checks. Nuclear magnetic resonance may be used for structural confirmation when available.
Mummies from Oceania are not limited only to Australia. Discoveries of mummified remains have also been located in New Guinea, New Zealand, and the Torres Strait, though these mummies have been historically harder to examine and classify. Prior to the 20th century, most literature on mummification in the region was either silent or anecdotal. However, the boom of interest generated by the scientific study of Egyptian mummification lead to more concentrated study of mummies in other cultures, including those of Oceania.
=== Complications === Metabolic syndrome can lead to type 2 diabetes, cardiovascular diseases, stroke, kidney disease, and nonalcoholic fatty liver disease. It is also associated with a moderately increased risk of surgical complications.
In chemistry, the biuret test (IPA: , ), also known as Piotrowski's test, is a chemical test used for detecting the presence of at least two peptide bonds in a molecule. In the presence of peptides, a copper(II) ion forms mauve-colored coordination complexes in an alkaline solution. The reaction was first observed in 1833. In Poland, the biuret test is also known as Piotrowski's test in honor of the Polish physiologist Gustaw Piotrowski who independently rediscovered it in 1857. Several variants on the test have been developed, such as the BCA test and the Modified Lowry test. The biuret reaction can be used to assess the concentration of proteins because peptide bonds occur with the same frequency per amino acid in the peptide. The intensity of the color, and hence the absorption at 540 nm, is directly proportional to the protein concentration, according to the Beer–Lambert law. Despite its name, the reagent does not in fact contain biuret [(H2N−CO−)2NH]. The test is so named because it also gives a positive reaction to the peptide-like bonds in the biuret molecule. In this assay, the copper(II) binds with nitrogen atoms present in the peptide bonds of proteins. In a secondary reaction, the copper(II) is reduced to copper(I). Buffers, such as Tris and ammonia interfere with this assay, therefore rendering this assay inappropriate for protein samples purified from ammonium sulfate precipitation. Due to its insensitivity and little interference by free amino acids, this assay is most useful for whole tissue samples and other sources with high protein concentration.
== Applications == Advanced Metering Infrastructure (AMI)/Advanced Meter Reading (AMR): provides two way meter communications, allowing commands to be sent toward the home for multiple purposes, including “time-of-use” pricing information, demand-response actions, or remote service disconnects. During periods of peak demand, utilities use these networks to throttle high-load devices in participating homes. Utilities may also institute time-of-use pricing schemes, where the home area network (HAN) is used to communicate the current price of energy to the consumer. Home Automation: allows household devices such as light switches and fixtures; thermostats and sensors; music, video and speaker systems; security controllers and appliances to network with one another to wirelessly automate the home. Hospitality: allows for wireless networking of the devices in the room without the need for a retrofit. The doors and the devices in the rooms can also be remotely monitored from a central location. Building Automation: provides building owners and property managers with HVAC, lighting, access and refrigeration control to monitor energy usage in real time to create more energy efficient environments. Asset Management: allows for remote monitoring and tracking of assets and cold chain. It also provides container security in shipping. Industrial Automation: wirelessly networks and automates industrial processes and allows for temperature, pressure and level sensing as well as providing temperature and flow control. Defense: provides both battlefield and shipboard monitoring.
Sources: en.wikipedia.org
=== Withdrawal === The incidence of antidepressant discontinuation syndrome symptoms in men using dapoxetine to treat PE has been described by reviewers as low or no different from the incidence of such symptoms in men withdrawn from placebo treatment. The lack of chronic serotonergic stimulation with on-demand dapoxetine minimizes the potentiation action of serotonin at synaptic cleft, thus decreasing the risk of discontinuation symptoms.
=== 1970 === January 15: The Nigerian Civil War ends with Biafra being re-integrated into Nigeria. March 5: Treaty on the Non-Proliferation of Nuclear Weapons, ratified by the United Kingdom, the Soviet Union and the United States, among others, enters into force. March 18: Lon Nol takes power in Cambodia and establishes the Khmer Republic. Khmer Rouge and Vietnamese Communists attack the new regime, which wants to end North Vietnamese presence in Cambodia. August 7: The War of Attrition ends with a ceasefire. August 12: The Soviet Union and West Germany sign the Treaty of Moscow. August 17: Venera 7 is launched. September 6: Black September begins in Jordan. October 24: Salvador Allende becomes president of Chile after being confirmed by the Chilean congress. November 18: United States' aid to Cambodia to support the Lon Nol regime begins. December 15: Venera 7 lands on Venus becoming the first spacecraft to softly land on another planet.
Dyson also did work in a variety of topics in mathematics, such as topology, analysis, number theory and random matrices. In 1973 the number theorist Hugh Lowell Montgomery was visiting the Institute for Advanced Study and had just made his pair correlation conjecture concerning the distribution of the zeros of the Riemann zeta function. He showed his formula to the mathematician Atle Selberg, who said that it looked like something in mathematical physics and that Montgomery should show it to Dyson, which he did. Dyson recognized the formula as the pair correlation function of the Gaussian unitary ensemble, which physicists have studied extensively. This suggested that there might be an unexpected connection between the distribution of primes (2, 3, 5, 7, 11, ...) and the energy levels in the nuclei of heavy elements such as uranium. Around 1979 Dyson worked with the Institute for Energy Analysis on climate studies. This group, under Alvin Weinberg's direction, pioneered multidisciplinary climate studies, including a strong biology group. Also during the 1970s, Dyson worked on climate studies conducted by the JASON defense advisory group. Dyson retired from the Institute for Advanced Study in 1994. In 1998 he joined the board of the Solar Electric Light Fund. In 2003 he was president of the Space Studies Institute, the space research organization founded by Gerard K. O'Neill; in 2013 he was on its board of trustees. Dyson was a longtime member of the JASON group. Dyson won numerous scientific awards, but never a Nobel Prize.
== Ketosis prone diabetes == The entity of ketosis-prone type 2 diabetes was first fully described in 1987 after several preceding case reports. It was initially thought to be a form of maturity onset diabetes of the young, and went through several other descriptive names (such as "idiopathic type 1 diabetes", "Flatbush diabetes", "atypical diabetes" and "type 1.5 diabetes") before the current terminology of "ketosis-prone type 2 diabetes" was adopted. It has been reported predominantly in non-white ethnicity in African–Americans, Hispanics, Black Africans and Black Caribbeans. There is a link with G6PD deficiency.
Another variety, the Hardangerlefse (from Hardanger in Norway), is made from yeast-risen Graham flour or a fine ground whole wheat flour (krotekake). It is often made with egg yolks and buttermilk instead of potatoes. The dough is rolled with a conventional rolling pin (and much more flour) until it is thin and does not stick to the surface. It is then cut with a grooved rolling pin in perpendicular directions, cutting a grid into the dough which prevents it from creating air pockets as it cooks. The grid cut can also aid in thinner rolling of the lefse, as the ridges help preserve structural integrity. The lefse is cooked at high temperature (400 °F or 205 °C) until browned, and then left to dry. It can also be freeze-dried by repeatedly freezing and thawing. Dried Hardangerlefse can be stored without refrigeration for six months or more, so long as it is kept dry. It is customarily thought that the bread (along with lutefisk) was a staple on the seagoing voyages as far back as Viking times. The dry lefse is dipped in water, and then placed within a towel which has also been dipped in water and wrung out. Many people maintain that dipping in salted or seawater enhances the flavor. The dry lefse regains its bread-like texture in about 60 minutes. Often that time is used to prepare such ingredients as eggs or herring, which are wrapped in the lefse once it has softened.
Sources: en.wikipedia.org
=== Primary and secondary schools === Cold Spring is served by ROCORI Independent School District 750. ROCORI stands for the three adjacent communities that primarily comprise the schools: Rockville, Cold Spring, and Richmond. Local public schools serving Cold Spring include John Clark Elementary, Cold Spring Elementary and Richmond Elementary, ROCORI Middle School, and Rocori High School. There are also three private schools in the district: St. Peter & Paul Elementary (preK-5) in Richmond, St. Boniface Elementary (preK-6) in Cold Spring, and Holy Cross School (preK-6) in Pearl Lake.
Amyloid-beta precursor protein (APP) is an integral membrane protein expressed in many tissues and concentrated in the synapses of neurons. It functions as a cell surface receptor and has been implicated as a regulator of synapse formation, neural plasticity, antimicrobial activity, and iron export. It is coded for by the gene APP and regulated by substrate presentation. APP is best known as the precursor molecule whose proteolysis generates amyloid beta (Aβ), a polypeptide containing 37 to 49 amino acid residues, whose amyloid fibrillar form is the primary component of amyloid plaques found in the brains of Alzheimer's disease patients.
On March 21, 2018, Starbucks announced that it was considering the use of blockchain technology to connect coffee drinkers with coffee farmers who could eventually be able to take advantage of new financial opportunities. The pilot program was planned to start with farmers in Costa Rica, Colombia, and Rwanda in order to develop a new way to track the bean-to-cup journey. In 2019, at the Microsoft Build conference, the coffee company formally announced its "bean to cup" program using the Microsoft's Azure-based blockchain service. Two men were arrested in a Philadelphia Starbucks location after a manager claimed the two were trespassing on April 12, 2018. The arrests led to protests due to their apparently racially motivated nature. CEO Kevin Johnson later apologized for the incident, and the company declined to press charges. During the company's second quarter earnings call on April 26, Johnson indicated that the company had not seen a drop in sales as a result of the event and subsequent coverage. The company reiterated its guidance for full year earnings, and beat consensus expectations of 1.8 percent same-store sales growth, with 2 percent growth. Johnson announced that the company would close some 8000 locations on May 29 for a seminar about racial bias in order to prevent future events similar to those that occurred in Philadelphia. On June 19, 2018, Starbucks announced the closing of 150 locations in 2019, three times the number the corporation typically closes in a single year. The closings were to happen in urban areas that already have dense clusters of stores.
=== Lymphoma === It is an unrare form of cancer that originates in the lymph system and causes the destructive effects in the immune system. There are two types of lymphoma, Hodgkin's lymphoma and non-Hodgkin's lymphoma. Both types of lymphomas form from a white blood cell or lymphocyte. Non-Hodgkin's lymphoma is the more common of the two cancers. The only way to tell these two forms of lymphoma apart is to perform a biopsy in order to get a microscopic view of the cancer cells. Hodgkin's lymphoma involves the abnormal growth of undifferentiated lymphocytes, while non-Hodgkin's lymphoma involves differentiated immune cells like B cells and T cells for example. Lutzner cells are involved with non-Hodgkin's lymphoma.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide analog of angiotensin IV, often described as an HGF mimetic in research literature. It is studied for effects on synaptic connectivity in laboratory models. It is not an approved medication.
No, dihexa is a synthetic compound derived from the structure of angiotensin IV. Angiotensin IV occurs naturally, but dihexa has modifications that change its properties. It is not a standard dietary component.
The main hypothesis is that dihexa interacts with the hepatocyte growth factor system, possibly through c-Met signaling. This interaction may influence synaptogenesis and neuronal plasticity. The exact molecular target remains an active area of study.
Published human clinical trial data are limited or absent. Most available evidence comes from laboratory and animal studies. Human safety and efficacy remain unresolved.